Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jianru Xiao"'
Publikováno v:
European Spine Journal. 29:3148-3156
Primary cancer patients may have some symptoms and develop spinal metastases in their disease progression. This study was to report the distribution and predictive value of specific initial presenting symptoms in patients with spine metastatic diseas
Autor:
Tao Wang, Zhipeng Wu, Haifeng Wei, Xin Gao, Shu Jun Lv, Yuduo Xu, Jian Zhao, Ming Qian, Wen Guo, Tianhui Hou, Zhenxi Li, Xiu Li, Jianru Xiao, Liang Tang
Publikováno v:
Oncology Letters
Breast cancer has a high prevalence in the general population and is often associated with bone metastasis. Specific therapeutic targets are missing for triple negative breast cancer (TNBC), which presents some immunogenic characteristics. Betulinic
Autor:
Kun Zhang, Liangliang Gao, Jianru Xiao, Liang Tang, Dongsheng Wang, Yao Wang, Chenglong Zhao, Jing Han, Zhenxi Li, Xin Gao
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, Vol 13, Iss, Pp 91-96 (2018)
Journal of Bone Oncology, Vol 13, Iss, Pp 91-96 (2018)
Patients with breast cancer are often afflicted by bone metastases, while the establishment and growth of bone metastases depend on interaction between cancer cells and the host environment. Moreover, osteoblasts, which play a vital role in cancer ce
Autor:
Shuang Liu, Lan Huang, Qingwei Wang, Jun Qin, Bianhong Zhang, Bert W. O’ Malley, Li Zhou, Yu Xiao, Yiyun Cheng, Da Wang, Xingli Zhou, Chuangui Wang, Xiaotao Li, Jianru Xiao, Geng Chen, Fuad Fares, Pei Zhang, Hui Chen, Xiao Gao, Robb E. Moses, Shihui Shen, Jian Liu, Ying Wang, Lei Li, Jiang Liu, David M. Lonard, Qing Zhang, Linian Pan, Syeda Kubra, Jiwei Chen, Zhipeng Wu
Publikováno v:
Nature communications, vol 11, iss 1
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
A major challenge in chemotherapy is chemotherapy resistance in cells lacking p53. Here we demonstrate that NIP30, an inhibitor of the oncogenic REGγ-proteasome, attenuates cancer cell growth and sensitizes p53-compromised cells to chemotherapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae26a81a122dcb00fda05db7661c1a86
https://escholarship.org/uc/item/5sr7j8wr
https://escholarship.org/uc/item/5sr7j8wr
Publikováno v:
Clinica Chimica Acta. 477:94-104
The alterations of lipid profile in cancer has been reported to be associated with cancer development. However, the prognostic value of serum lipid markers level in cancer is currently under debate. Here we performed a meta-analysis to investigate th
Autor:
Chenglong Zhao, Wangjun Yan, Wending Huang, Yan-Mei Wu, Jianru Xiao, Bo Li, Heng-Yu Li, Weiluo Cai, Zhenxi Li, Tianrui Chen
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-14 (2018)
Molecular Cancer
Molecular Cancer
Background Most patients with breast cancer in advanced stages of the disease suffer from bone metastases which lead to fractures and nerve compression syndromes. microRNA dysregulation is an important event in the metastases of breast cancer to bone
Publikováno v:
Biomaterials. 265:120404
A variety of targeted nanoparticles were developed for the diagnosis and therapy of orthotopic and metastatic bone tumors during the past decade. This critical review will focus on principles and methods in the design of these bone-targeted nanoparti
Autor:
Zhenxi Li, Ming Qian, Zhipeng Wu, Chenglong Zhao, Ming Zhou, Wei Xu, Yingzheng Ji, Haifeng Wei, Tianhui Hou, Jian Zhao, Liang Tang, Yan Lou, Jianru Xiao, Shichang Li, Dongsheng Wang
Publikováno v:
Oncology Letters
Breast cancer (BC) is characterized by high incidences of bone metastases. Current treatment strategies for BC bone metastases primarily focused on breaking the ‘vicious osteolytic cycle’. Platelet-activating factor (PAF) is a potent phospholipid
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 483
Inflammation biomarkers have been introduced into clinical practice for risk-rating in treatment of patients with cancer. We aimed to confirm the prognostic role of platelet-to-lymphocyte ratio (PLR) as a powerful biomarker for patients with advanced
Autor:
Ming Qian, Yan Lou, Dongyu Peng, Jianru Xiao, Haiyi Gong, Zhenxi Li, Wangjun Yan, Jian Zhao, Xinghai Yang
Osteosarcoma (OS) is the most common type of primary bone tumor and accounts for ~60% of all malignant bone tumors in children and adolescents. A large number of studies have proposed that the dysregulated and dysfunctional microRNAs may serve import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1892f59b10fe6244389bfedf0ce477f3
https://europepmc.org/articles/PMC5934716/
https://europepmc.org/articles/PMC5934716/